Browse hierarchy: [Clinical Chemistry (CH)](/submissions/CH) → [Subpart B — Clinical Chemistry Test Systems](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems) → [21 CFR 862.1775](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/862.1775) → LFQ — Acid, Uric, Acid Reduction Of Ferric Ion

# LFQ · Acid, Uric, Acid Reduction Of Ferric Ion

_Clinical Chemistry · 21 CFR 862.1775 · Class 1_

**Canonical URL:** https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/LFQ

## Overview

- **Product Code:** LFQ
- **Device Name:** Acid, Uric, Acid Reduction Of Ferric Ion
- **Regulation:** [21 CFR 862.1775](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/862.1775)
- **Device Class:** 1
- **Review Panel:** [Clinical Chemistry](/submissions/CH)

## Identification

A uric acid test system is a device intended to measure uric acid in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of numerous renal and metabolic disorders, including renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and of patients receiving cytotoxic drugs.

## Classification Rationale

Class I (general controls). The device, when it is solely intended for use as an acid reduction of ferric ion test, a phosphotungstate reduction test, a gasometric uricase test, an ultraviolet uricase test, or an oxygen rate uricase test, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

## Recent Cleared Devices (5 of 5)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K860111](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/LFQ/K860111.md) | URIC ACID REAGENT SET | Technostics Intl. | Feb 19, 1986 | SESE |
| [K860142](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/LFQ/K860142.md) | URIC ACID REAGENT SET (COLORIMETRIC) | Sterling Diagnostics, Inc. | Feb 11, 1986 | SESE |
| [K844075](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/LFQ/K844075.md) | URIC ACID REAGENT SET | Livonia Diagnostics, Inc. | Oct 30, 1984 | SESE |
| [K812313](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/LFQ/K812313.md) | SANDARE URIC ACID PROCEDURE | Sandare Chemical Co., Inc. | Sep 1, 1981 | SESE |
| [K811764](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/LFQ/K811764.md) | URIC ACID REAGENT SET | Anco Medical Reagents & Assoc. | Aug 20, 1981 | SESE |

## Top Applicants

- Anco Medical Reagents & Assoc. — 1 clearance
- Livonia Diagnostics, Inc. — 1 clearance
- Sandare Chemical Co., Inc. — 1 clearance
- Sterling Diagnostics, Inc. — 1 clearance
- Technostics Intl. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/LFQ](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/LFQ)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com
